Agio Pharmaceuticals Limited — Salicylic Exporter Profile
Indian Pharmaceutical Exporter · #10 for Salicylic · $281.8K export value · DGFT Verified
Agio Pharmaceuticals Limited is the #10 Indian exporter of Salicylic with $281.8K in export value and 19 verified shipments. Agio Pharmaceuticals Limited holds a 1.7% market share in Salicylic exports across 2 countries. The company exports 15 pharmaceutical products worth $11.9M across 8 therapeutic categories.
Agio Pharmaceuticals Limited — Salicylic Export Profile: Buyers & Destinations
Where Does Agio Pharmaceuticals Limited Export Salicylic?
| Country | Value | Shipments | Share |
|---|---|---|---|
| RUSSIA | $237.6K | 14 | 84.3% |
| SRI LANKA | $44.2K | 5 | 15.7% |
Agio Pharmaceuticals Limited exports Salicylic to 2 countries. The largest destination is RUSSIA accounting for 84.3% of Agio Pharmaceuticals Limited's Salicylic shipments. These destinations reflect Agio Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Salicylic from Agio Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AGIO RUS LLC | RUSSIA | $237.6K | 14 |
| TO THE ORDER OF COMMERCIAL | SRI LANKA | $18.1K | 3 |
| TO THE ORDER OF COMMERCIAL BANK OF | SRI LANKA | $17.4K | 1 |
| CITIHEALTH IMPORTS PRIVATE LIMITED | SRI LANKA | $8.7K | 1 |
Agio Pharmaceuticals Limited supplies Salicylic to 4 buyers globally. The largest buyer is AGIO RUS LLC (RUSSIA), followed by TO THE ORDER OF COMMERCIAL (SRI LANKA) and TO THE ORDER OF COMMERCIAL BANK OF (SRI LANKA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Salicylic Export Value and How Much Does Agio Pharmaceuticals Limited Contribute?
India exported $12.5M worth of Salicylic through 2,799 shipments from 276 suppliers to 132 countries, serving 632 buyers globally. Agio Pharmaceuticals Limited contributes $281.8K to this total, accounting for 1.7% of India's Salicylic exports. Agio Pharmaceuticals Limited ships Salicylic to 2 countries through 4 buyers.
What Is the Average Shipment Value for Agio Pharmaceuticals Limited's Salicylic Exports?
Agio Pharmaceuticals Limited's average Salicylic shipment value is $14.8K per consignment, based on 19 shipments totaling $281.8K. The largest destination is RUSSIA (84.3% of Agio Pharmaceuticals Limited's Salicylic exports).
How Does Agio Pharmaceuticals Limited Compare to Other Indian Salicylic Exporters?
Agio Pharmaceuticals Limited ranks #10 among 276 Indian Salicylic exporters with a 1.7% market share. The top 3 exporters are RECKITT BENCKISER (INDIA) PRIVATE LIMITED ($3.6M), RECKITT BENCKISER INDIA PRIVATE LIMITED ($2.2M), CIPLA LIMITED ($2.0M). Agio Pharmaceuticals Limited processed 19 shipments to 2 destination countries.
What Salicylic Formulations Does Agio Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| EXOBETA S OINTMENT (BETAMETHASONE DIPROPIONATE & SALICYLIC ACID OINTMENT) | $192.6K | 8 |
| EXOBETA S OINTMENT BETAMETHASONE DIPROPIONATE & SALICYLIC ACID OINTMENT | $43.6K | 2 |
| BETACYLIC (BETAMETHASONE DIPROP. 0.05% &SALICYLIC ACID 3% OINT.) | $18.1K | 3 |
| BETACYLIC (BETAMETHASONE DIPROP. 0.05% &SALICYLIC ACID 3% OINT) | $17.4K | 1 |
| BETACYLIC BETAMETHASONE DIPROP. 0.05% &SALICYLIC ACID 3% OINT | $8.7K | 1 |
| EXOBETA S OINTMENTBETAMETHASONE DIPROPIONATE & SALICYLIC ACID OINTMENTBNO.E23343 & E23344 MD.9/23ED.8/25PACK OF 30GM | $1.1K | 2 |
| EXOBETA S OINTMENTBETAMETHASONE DIPROPIONATE & SALICYLIC ACID OINTMENTBNO.E23345 MD.09/23ED.08/25PACK OF 15GM | $357 | 2 |
Agio Pharmaceuticals Limited exports 7 distinct Salicylic formulations including tablets, capsules, syrups, and combination drugs. The top formulation is EXOBETA S OINTMENT (BETAMETHASONE DIPROPIONATE & SALICYLIC A with 8 shipments worth $192.6K.
How Does Agio Pharmaceuticals Limited Compare to Nearest Salicylic Exporters?
Exporters ranked immediately above and below #10 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | UNILINK PHARMA PRIVATE LIMITED | $550.0K | 11 | 2 | $50.0K |
| 9 | MEDINOMICS HEALTH CARE PRIVATE LIMITED | $295.0K | 7 | 1 | $42.1K |
| 10 | AGIO PHARMACEUTICALS LIMITED ★ | $281.8K | 19 | 2 | $14.8K |
| 11 | VARDHMAN EXPORTS | $273.6K | 16 | 4 | $17.1K |
| 12 | MSN LABORATORIES PRIVATE LIMITED | $263.2K | 12 | 1 | $21.9K |
Agio Pharmaceuticals Limited ranks #10 among 276 Indian Salicylic exporters. Average shipment value of $14.8K compared to the market average of $45.4K. The closest competitors by value are UNILINK PHARMA PRIVATE LIMITED and MEDINOMICS HEALTH CARE PRIVATE LIMITED.
Which Indian Ports Ship Salicylic Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 412 | 14.7% |
| BANGALORE ICD | 324 | 11.6% |
| DELHI AIR CARGO ACC (INDEL4) | 319 | 11.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 268 | 9.6% |
| DELHI AIR | 201 | 7.2% |
| NHAVA SHEVA SEA (INNSA1) | 134 | 4.8% |
| JNPT/ NHAVA SHEVA SEA | 111 | 4.0% |
| JNPT | 109 | 3.9% |
Geopolitical & Trade Policy Impact on Agio Pharmaceuticals Limited's Salicylic Exports
Recent geopolitical developments have introduced complexities into the pharmaceutical export landscape. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight charges and potential losses for Indian exporters. According to Pharmaceutical Commerce, maritime carriers' booking suspensions and diversions around the Cape of Good Hope are elongating lead times and pressurizing Suez-linked lanes, disproportionately impacting time-sensitive pharmaceutical replenishment cycles. This situation poses challenges for Agio Pharmaceuticals, particularly in maintaining timely deliveries to key markets.
In the United States, recent tariff implementations have affected a significant portion of Indian exports. The Federation of Indian Export Organisations highlighted that the latest U.S. tariffs impact nearly 55% of India's outbound shipments to America, placing Indian exporters at a competitive disadvantage. For Agio, which relies on the U.S. market, these tariffs could necessitate strategic adjustments to pricing and supply chain logistics.
The European Union's stringent regulatory changes, including the Falsified Medicines Directive, demand enhanced compliance measures from exporters. Agio's ability to adapt to these evolving standards will be crucial in sustaining its market presence in the EU.
Agio Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the U.S. FDA increasing inspections of manufacturing facilities. India, hosting over 600 US FDA-approved sites, faces challenges in maintaining compliance. The US FDA conducted more than 200 inspections in 2023, with plans to increase this number in 2024. For Agio Pharmaceuticals, ensuring adherence to Good Manufacturing Practices (GMP) and other quality standards is imperative to avoid potential export bans or reputational damage.
Additionally, the prevalence of counterfeit drugs has raised concerns about India's reputation as a reliable supplier. Agio must implement robust quality control systems and transparent governance to navigate this landscape effectively.
About Agio Pharmaceuticals Limited
Agio Pharmaceuticals Limited exports 15 products worth $11.9M. Beyond Salicylic, top products include Dexamethasone, Phenylephrine, Clotrimazole, Prednisolone, Salbutamol. View the complete Agio Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Salicylic — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Salicylic shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Agio Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 19 individual customs records matching Agio Pharmaceuticals Limited exporting Salicylic, covering 7 formulations to 2 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 132+ countries, 632+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Salicylic Export Data from Agio Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Agio Pharmaceuticals Limited's Salicylic exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Agio Pharmaceuticals Limited
Full Company Profile →
15 products · $11.9M total trade · 8 categories
Salicylic Stats
Company Overview
Top Products by Agio Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Agio Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Salicylic. For current shipment-level data, contact TransData Nexus.